Sexual health in women with breast cancer treated with Tamoxifen
DOI:
https://doi.org/10.19230/jonnpr.3982Keywords:
Sexual Health, Women, Breast Cancer, Tamoxifen, Sexuality, Breast, SERMAbstract
Breast cancer can alter certain components of sexual function due to the disease and the treatments used.
Objetive. To analyze if patients with breast cancer treated with Tamoxifen have sexual dysfuntion.
Method. Cross-sectional, observational study to detect sexual dysfunction in patients with breast cancer with Tamoxifen treatment and compare it with general population. The cases of breast cancer at Virgen de La Luz Hospital from April 2015 to April 2016 have been analyzed, selecting women in treatment with tamoxifen, under 50 years and sexually active, applying a sexual health questionnarie and comparing them with general population.
Results. 130 breast cancers were diagnosed, 34 were susceptible to study (26,15%). Seven patients (20,6%) participated, with a mean age of 42,7 years (35-50) and stable partner in 85,7%. Moderate disorders of sexual desire have been observed in 28,6% and in arousal in 14,28%, as well as lack of sexual initiative in 42,86%, disorder of vaginal lubrication in 28,6% and problems with vaginal penetration in 14,3%, but overall they are satisfied with their sexual activity. Comparing with general population, it´s striking that 14,2% of the last show some degree of sexual insatisfaction.
Conclusions. There are no significant differences regarding sexual dysfunction, although there may be greater anticipatory anxiety, sexual desire dysfunction and vaginal lubrication in the Tamoxifen group, which probably do not reach statistical significance due to sample size.
Downloads
References
Davies C, Godwin J, Gray R, Clarke M, Cutter D et al. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Lancet. 2011;378:771. Epub 2011 Jul 28.
Azim HA Jr, Davidson NE, Ruddy KJ. Challenges in Treating Premenopausal Women with Endocrine-Sensitive Breast Cancer. Am Soc Clin Oncol Educ Book. 2016;35:23-32.
Shandiz FH, Karimi FZ, Rahimi N, Abdolahi M, Anbaran ZK et al. Investigating Sexual Function and Affecting Factors in Women with Breast Cancer in Iran. Asian Pac J Cancer Prev. 2016;17:3583-6.
Sbitti Y, Kadiri H, Essaidi I, Fadoukhair Z, Kharmoun S et al. Breast cancer treatment and sexual dysfunction: Moroccan women's perception. BMC Womens Health. 2011;11:29.
Saghatchian M, Lesur A. Management of side effects related to adjuvant hormone therapy in young women with breast cancer. Bull Cancer. 2019;106:37-42.
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
